Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lenroot, R.
* Articles by Keith, S. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lenroot, R.
* Articles by Keith, S. J.
Related Collections
* Patients' Families
* Treatment Compliance
* Atypical Neuroleptics
* Psychotherapies (General)
* Conventional Neuroleptics
* Schizophrenia Spectrum Disorders
Psychiatr Serv 54:1499-1507, November 2003
© 2003 American Psychiatric Association

Integration of Care: Integrated Treatment of Schizophrenia

Roshel Lenroot, M.D., Juan R. Bustillo, M.D., John Lauriello, M.D. and Samuel J. Keith, M.D.

The importance of combining psychosocial and pharmacologic interventions for optimum outcome in the treatment of schizophrenia is now well recognized. However, less research is available on ways in which the two types of treatment may affect each other. This article reviews research and principles applying to the integrated use of current psychosocial and pharmacologic treatments for schizophrenia. Emphasis is placed on areas of interaction, including patient adherence and the effect of antipsychotic medications on cognitive functioning. Recommendations are presented for specific clinical situations.




This article has been cited by other articles:


Home page
Int J Soc PsychiatryHome page
J. H. Jenkins, M. E. Strauss, E. A. Carpenter, D. Miller, J. Floersch, and M. Sajatovic
Subjective Experience of Recovery from Schizophrenia-Related Disorders and Atypical Antipsychotics
International Journal of Social Psychiatry, September 1, 2005; 51(3): 211 - 227.
[Abstract] [PDF]


Home page
FocusHome page
R. D. Jindal and M. E. Thase
Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Focus, January 1, 2005; 3(1): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
S. J. Keith, L. Pani, B. Nick, R. Emsley, L. San, M. Turner, R. Conley, P. Scully, P. S. Chue, and B. Lachaux
Practical Application of Pharmacotherapy With Long-Acting Risperidone for Patients With Schizophrenia
Psychiatr Serv, September 1, 2004; 55(9): 997 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. D. Jindal and M. E. Thase
Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Psychiatr Serv, November 1, 2003; 54(11): 1484 - 1490.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org